Hannah Valantine

BBIO

Hannah Valantine serves as director at BridgeBio Pharma, Inc. (BBIO). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$69.6K

Total Sells

11 trades

$5.44M

Net Position

Net Seller

$5.37M

Companies Traded

BBIO, CDNA

Active Period

Dec 2021 – Mar 2026

13 total trades

Most Recent

Sell BBIO

Mar 12, 2026 · $624.3K

Hannah Valantine's Insider Trading at BridgeBio Pharma, Inc. (BBIO)

Buys

2 · $69.6K

Sells

10 · $5.24M

Total Shares Bought

5,197

Total Shares Sold

93,173

BBIO Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 12, 2026	Sell	8,671	$72.00	$624.3K	7,465
Mar 3, 2026	Sell	25,484	$67.41	$1.72M	18,365
Nov 12, 2025	Sell	25,484	$66.07	$1.68M	0
Jun 26, 2025	Sell	4,707	$44.05	$207.3K	0
Jun 10, 2025	Sell	4,292	$40.00	$171.7K	0
Mar 6, 2025	Sell	12,875	$32.58	$419.5K	0
Feb 15, 2024	Sell	2,915	$37.75	$110.0K	0
Jan 16, 2024	Sell	2,915	$37.97	$110.7K	0
Dec 15, 2023	Sell	2,915	$36.12	$105.3K	0
Nov 15, 2023	Sell	2,915	$30.00	$87.5K	0
Dec 29, 2021	Buy	1,764	$14.23	$25.1K	0
Dec 28, 2021	Buy	3,433	$12.96	$44.5K	0